EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 57 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $463,000 | -45.2% | 54,254 | -25.8% | 0.00% | -100.0% |
| Q4 2020 | $845,000 | +45.4% | 73,121 | +5.6% | 0.00% | – |
| Q3 2020 | $581,000 | -16.8% | 69,257 | -7.8% | 0.00% | -100.0% |
| Q2 2020 | $698,000 | +84.2% | 75,138 | +7.0% | 0.00% | – |
| Q1 2020 | $379,000 | -50.1% | 70,240 | +37.6% | 0.00% | -100.0% |
| Q4 2019 | $760,000 | +2614.3% | 51,052 | +1753.7% | 0.00% | – |
| Q3 2019 | $28,000 | 0.0% | 2,754 | +3.7% | 0.00% | – |
| Q2 2019 | $28,000 | +600.0% | 2,657 | +785.7% | 0.00% | – |
| Q2 2018 | $4,000 | -96.7% | 300 | -97.6% | 0.00% | – |
| Q1 2018 | $122,000 | +12100.0% | 12,484 | +12260.4% | 0.00% | – |
| Q4 2016 | $1,000 | – | 101 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 1,787,091 | $20,462,000 | 6.02% |
| INTERWEST VENTURE MANAGEMENT CO | 1,599,592 | $18,315,000 | 3.89% |
| NEXTHERA CAPITAL LP | 263,600 | $3,018,000 | 1.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 385,301 | $4,412,000 | 0.86% |
| RA Capital Management | 354,200 | $4,056,000 | 0.50% |
| DAFNA Capital Management LLC | 35,977 | $412,000 | 0.35% |
| Boxer Capital, LLC | 138,331 | $1,584,000 | 0.35% |
| SABBY MANAGEMENT, LLC | 238,907 | $2,735,000 | 0.15% |
| Monashee Investment Management LLC | 31,500 | $361,000 | 0.14% |
| Lombard Odier Asset Management (USA) Corp | 100,000 | $1,145,000 | 0.11% |